The goal of the New Jersey State Opioid Response (NJ-SOR) is to address the opioid crisis confronting the state using a variety of strategies. The key objectives are to increase access to medication assisted treatment (MAT), reduce unmet treatment need and reduce opioid related deaths. To address these objectives, the New Jersey Division of Mental Health and Addiction Services (DMHAS) will develop infrastructure support to provide buprenorphine in standard outpatient and intensive outpatient substance use disorder (SUD) treatment as well as a low-threshold buprenorphine induction program. A new mobile van pilot program will be developed to facilitate low induction medication, case management and other ancillary services for individuals with an opioid use disorder (OUD) in communities with low access to MAT and high rates of homelessness. Additionally, a program will be developed to enhance overall recovery in stimulant use disorders utilizing contingency management. A public information, education, and training campaign will be launched to reduce discrimination and promote MAT as the evidence-based practice (EBP) for OUD. Additionally, opportunities for training, professional development and wellness services will be developed for OUD treatment professionals, as well as, recovery service workers.
Prevention efforts will include expanding the target groups that receive naloxone training and kits through the Robert Wood Johnson Medical School and Opioid Overdose Prevention Program (OOPP), as well as, expanding the availability of naloxone kits to high risk populations through partnerships with New Jersey's seven Harm Reduction Centers and statewide distribution events. Recovery activities will include a continuation of the Opioid Overdose Recovery Programs (OORP) and the Support Team for Addiction Recovery programs (STAR).
Anticipated outcomes of the SOR include: reduction/abstinence from drugs and alcohol, increase in employment, reduced criminal justice involvement, increased social connectedness, and increased percentage of individuals completing treatment at the recommended level of care. Additional outcomes include: reducing opioid overdoses, increasing retention in treatment, reducing the length of time to relapse and prolonging recovery, and increasing number of individuals receiving MAT. It is estimated that SOR will serve 34,178 individuals during the first year and 68,356 individuals over the two-year project.